Hospital Pharmacy Europe

MAY 1, 2025

Consistent adherence to pulmonary hypertension-specific oral therapy significantly improves clinical outcomes, according to a new prospective study evaluating patients with pulmonary arterial hypertension (PAH) and distal chronic thromboembolic pulmonary hypertension (CTEPH). These two conditions are progressive, life-limiting diseases where timely, consistent medication use is critical to stabilise symptoms and prolong survival.

Hospitals

The Checkup by Singlecare

MAY 1, 2025

Prednisone is a type of medication called an oral corticosteroid. Its used to treat inflammation in the body, from conditions like allergies, asthma, arthritis, blood disorders, cancer, autoimmune diseases, and various skin conditions. Prednisone can also be used to calm an overactive immune system. If you are dealing with an itchy, uncomfortable case of poison ivy , you might be wondering if you can use prednisone for poison ivy.

Immunization

Hospital Pharmacy Europe

MAY 1, 2025

As the NHS advances, effective clinical leadership in pharmacy is vital to improve the pharmaceutical care of patients. In Scotland, the Scottish Pharmacy Clinical Leadership Fellowship scheme aims to support just that, as Gerry Hughes finds out. The goal of the Scottish Pharmacy Clinical Leadership Fellowship , launched in 2018, is to nurture future pharmacy leaders and advance strategic healthcare goals in Scotland.

Patient Care

STAT

MAY 1, 2025

The era of “tranq” may be ending. But tranq, as the powerful veterinary tranquilizer xylazine is known in the illicit drug supply, is being replaced at least in part by a dangerous new sedative: medetomidine. In the past year, the anesthetic has become an increasingly common element in the drug supply, with cities and states including Philadelphia, Pittsburgh, Chicago, and San Francisco reporting cases of medetomidine-involved overdoses.

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

European Pharmaceutical Review

MAY 1, 2025

Novartis AG has agreed to acquire the biopharmaceutical company Regulus Therapeutics Inc. This deal has potential total equity value of up to approximately $1.7 billion. It involves supporting advancement of Regulus’ lead product candidate, farabursen (RGLS 8429), a microRNA-17 (miR-17) inhibitor being developed to treat autosomal dominant polycystic kidney disease (ADPKD).

STAT

MAY 1, 2025

As a professor of physiology, I study how scientific evidence gets translated, sometimes clumsily, from the lab to real life. Whether it’s scaling dietary supplements to humans or using biomimicry to mitigate sports concussion , my work often centers on the fine line between meaningful evidence and misleading extrapolation. That’s why I was immediately skeptical when the Food and Drug Administration announced its decision to ban synthetic food dyes like the controversial red dye No

STAT

MAY 1, 2025

Shares of Eli Lilly dropped in pre-market trading Thursday, as competitor Novo Nordisk secured a major win on insurance coverage of its obesity drug and as Lilly reported first-quarter earnings that fell short of what investors wanted to see. CVS Caremark, the largest pharmacy benefit manager in the U.S., announced Thursday that starting in July, Novo’s weight loss treatment Wegovy will be the preferred GLP-1 medicine on its largest commercial formularies, likely making Wegovy more access

Insurance Coverage

Pharmafile

MAY 1, 2025

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics 2025 acceleration programme, a prestigious initiative designed to help Nordic growth companies expand into the US market. Organised by the Swedish-American Chamber of Commerce in New York (SACCNY) in partnership with EY, the programme provides selected companies with access to US investor networks, […] The post Neogap chosen for Innovate Nordics 2025 Acceleration Programme appeared first on Pharmafile.

STAT

MAY 1, 2025

The recent news that the NIH will require universities to certify their diversity programs comply with federal civil rights law created understandable anxiety in the academic community. The confusion is partly due to coverage that suggested NIH is terminating support for any universities that operate diversity, equity, and inclusion (DEI) programs. But reading the actual NIH notice carefully provides clarity — and perhaps some reassurance.

Oswald's

MAY 1, 2025

When I returned to Oswalds Pharmacy in 2016, one of the first things I did was sit down with my grandparents, Bob and Jean Andersonthe fourth-generation owners of the business. Theyve lived in the same Naperville home that my great-great-great-grandfather, William Wallace Wickel, built back in 1892. Its a house filled with stories even if some are a little fuzzy.

Independent Pharmacies

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 1, 2025

Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is lavender vanilla.

Insurance Coverage

Pharmafile

MAY 1, 2025

Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its new chief executive officer (CEO). This supports Tozaros intent to accelerate the commercialisation of its Smart Polymer technology, which aims to enhance downstream viral vector manufacturing in CGT. Slingsby succeeds interim CEO Guy Leaver, who […] The post Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy se

STAT

MAY 1, 2025

CVS Health will not sell its Aetna health plans in the Affordable Care Act’s individual marketplaces in 2026, marking the second time in the past decade that Aetna has given up on ACA coverage. CVS expects to lose up to $400 million this year in its ACA plans. The conglomerate set aside $448 million in the first quarter to cover medical claims from ACA members that won’t be covered by insurance premiums.

Insurance

Pharmafile

MAY 1, 2025

Clinigen, the global pharmaceutical services group, has announced key leadership changes to accelerate its growth and strengthen its position in the expanding biopharma services market. Nihad Hasagic (pictured left) has been appointed senior vice president (SVP) of Clinigen Lifecycle Services (CLS), reporting directly to CEO Jerome Charton. CLS supports pharmaceutical and biotech clients across the […] The post Clinigen announces executive appointments to drive growth and investor value ap

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

MAY 1, 2025

WASHINGTON — Democratic lawmakers in Congress, including a member of the influential Senate Finance Committee, are pushing back on health secretary Robert F. Kennedy Jr.’s decision to suspend public comment on much of his agency’s business.  Sen. Ron Wyden (D-Ore.) and other House and Senate Democrats introduced twin resolutions in Congress Thursday calling on the administration to reverse course.

Hospitals

Pharma Marketing Network

MAY 1, 2025

Introduction In the rapidly evolving pharmaceutical landscape, staying abreast of emerging pharma trends is crucial for maintaining a competitive edge. As we navigate through 2025, several key developments are reshaping the industry, from technological advancements to regulatory reforms. Understanding these trends not only aids in strategic planning but also ensures alignment with industry standards and patient expectations.

Communication

STAT

MAY 1, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Biotech mood check: Happy Two acquisitions. Strong drug launches. FDA drug approvals. A rebounding XBI now 18% higher from its recent low.  All in, a very pleasant week so far.

FDA

Drug Topics

MAY 1, 2025

The Inflation Reduction Act's drug price negotiations could lead to reimbursement complexities, potential pharmacy closures, and reduced patient access to medications, particularly specialty drugs.

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PhRMA

MAY 1, 2025

Patients in the U.S. will soon be left with fewer new, affordable and convenient treatments, if Congress fails to fix a harmful provision in the Inflation Reduction Act (IRA) referred to as the “pill penalty.

Drug Topics

MAY 1, 2025

In the researchers review of data since 1990, they explored the global burden of infertility and the extent in which it is caused by either STIs or maternal sepsis.

PhRMA

MAY 1, 2025

The 340B hospital markup program continues to skyrocket every year. Yet there is little to no evidence that this immense growth is benefiting the uninsured and low-income patients that the program was designed to serve. If the money isn’t going to help patients, where is it going?

Hospitals

Drug Topics

MAY 1, 2025

A conversation with Sarah Thomas and David Skomo of HealthDyne at Asembias AXS25 Summit.

Patient Care

PharmaVoice

MAY 1, 2025

Turmoil at the NIH has led to handwringing among researchers and drugmakers who rely on public funding.

Drug Topics

MAY 1, 2025

Douglas Hoey, CEO of NCPA, discusses what pharmacies can do to increase revenue and avoid shutting their doors.

Independent Pharmacies

Pharmacy Times

MAY 1, 2025

In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.

FDA

Drug Topics

MAY 1, 2025

Although the market is expected to continue to become more popular, compounding pharmacies will no longer be allowed to manufacture these medications, as shortages have been listed as resolved.

Compounding Pharmacies

Pharmacy Times

MAY 1, 2025

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.

Patient Care

Drug Topics

MAY 1, 2025

Amid record levels of advertisements for lifestyle medications on social media, Luke Turnock, PhD, discusses the global impact these trends may have on patients.

Fierce Healthcare

MAY 1, 2025

The filing also names brokers eHealth, GoHealth and SelectQuote as defendants, and claims the insurers paid kickbacks to boost Medicare Advantage enrollment.

Insurance

Pharmacy Times

MAY 1, 2025

Cimerli offers a promising biosimilar treatment for age-related macular degeneration, enhancing vision preservation with its effective VEGF inhibition.

pharmaphorum

MAY 1, 2025

The US will spend $500m to develop universal vaccines to protect against multiple virus variants, while changes to testing rules are raising concerns

Vaccines

Fierce Healthcare

MAY 1, 2025

Federal contractor Peraton is attempting to help CMS and DOGE crack down on waste, fraud and abuse with a new commercial offering that is supposed to deliver a 100x return on investment.

PharmaVoice

MAY 1, 2025

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in annual sales at its peak.

Immunization